Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

The results of genetic testing can have a profound impact on treatment options and preventive measures for breast cancer. If ...

Men with BRCA1 and BRCA2 gene mutations should be given annual prostate cancer screening checks, leading scientists have said ...

I understand surgery is often included as part of the treatment plan for breast cancer. If I'm a candidate for lumpectomy but ...

Inherited mutations in the gene BRCA2 significantly increase the risk of carriers to breast and ovarian cancers. BRCA2, a crucial player in the body's DNA repair system, aids in repairing damaged DNA.

When Jody Bews-Hair last spoke to the Weekly a decade ago, she was adjusting to life after being diagnosed with the BRCA2 ...

An international study led by researchers at Memorial Sloan Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing ...

Mathew Knowles gets candid about surviving breast cancer and living with the BRCA2 gene mutation. Mathew Knowles is honoring Breast Cancer Awareness Month by opening up about his own experience as a ...

October is Breast Cancer Awareness Month, and one Wood County woman hopes sharing her story will inspire others to take ...

Adding PARP inhibitor niraparib to standard prostate cancer treatment delays disease progression in men with certain DNA ...

The BRCA gene mutation is most commonly associated with breast cancer. But it can also potentially affect one's risk for other cancers. Here's what to know. Breast cancer has long been on people’s ...